{
    "nct_id": "NCT06485778",
    "official_title": "Phase 2 Single Arm Trial of Adjuvant Nodal Irradiation Alone in Post Operative Oral Tongue Squamous Cell Carcinoma",
    "inclusion_criteria": "* Age ≥ 18\n* Surgical resection of all gross disease without evidence of residual loco-regional disease on simulation PET/CT.\n* pT1-2,pN0-2b Squamous Cell Carcinoma of the Oral Tongue confirmed on final surgical pathology. Patients must have:\n\n  * at least two of the following pathologic risk features\n\n    * LVI\n    * DOI ≥ 4mm OR\n  * 1 or 2 pathologically positive nodes N1 to low volume N2b.\n* Primary specimen surgical margins ≥3 mm\n* Signed informed consent form by the participant or their legally authorized representative (LAR)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* N2c/N3 nodal disease\n* >2 pathologically positive nodes\n* Primary specimen surgical margin < 3 mm\n* Extensive Perineural Invasion (PNI); non-extensive PNI is permitted.\n* Extra-capsular extension in any pathologically positive lymph node\n* Surgery at outside institution (PI can give approval for patients operating on outside)\n* Prior or simultaneous invasive malignancy that, in the opinion of the PI, represents a competing risk of death equivalent to the patient's oral tongue squamous cell carcinoma.\n* Auto-immune conditions that would otherwise preclude radiation in the opinion of the PI (e.g. Scleroderma).\n* Lack of ability to understand and willingness to sign a written informed consent and complete questionnaires.",
    "miscellaneous_criteria": ""
}